ES506320A0 - Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. - Google Patents

Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Info

Publication number
ES506320A0
ES506320A0 ES506320A ES506320A ES506320A0 ES 506320 A0 ES506320 A0 ES 506320A0 ES 506320 A ES506320 A ES 506320A ES 506320 A ES506320 A ES 506320A ES 506320 A0 ES506320 A0 ES 506320A0
Authority
ES
Spain
Prior art keywords
enhibidor
liposomes
protease
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506320A
Other languages
English (en)
Spanish (es)
Other versions
ES8306323A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of ES8306323A1 publication Critical patent/ES8306323A1/es
Publication of ES506320A0 publication Critical patent/ES506320A0/es
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES506320A 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. Granted ES506320A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
ES8306323A1 ES8306323A1 (es) 1983-05-16
ES506320A0 true ES506320A0 (es) 1983-05-16

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506320A Granted ES506320A0 (es) 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Country Status (5)

Country Link
JP (1) JPS5770814A (enrdf_load_stackoverflow)
DE (1) DE3141223A1 (enrdf_load_stackoverflow)
ES (1) ES506320A0 (enrdf_load_stackoverflow)
FR (1) FR2492260A1 (enrdf_load_stackoverflow)
GB (1) GB2085729B (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (it) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
FR2581543B1 (fr) * 1985-05-09 1989-07-07 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (fr) * 1993-06-18 1995-08-18 Franche Comte Universite Produit alcalinisant sous forme gastro-résistante.
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
CH689139A5 (de) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
WO1999011242A1 (en) * 1997-09-04 1999-03-11 Biozone Laboratories, Inc. Oral liposomal delivery system
PT2193809E (pt) 1999-02-22 2015-08-24 Baxter Int Formulações de fator viii livres de albumina
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN109316599A (zh) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.

Also Published As

Publication number Publication date
JPH03366B2 (enrdf_load_stackoverflow) 1991-01-07
ES8306323A1 (es) 1983-05-16
GB2085729B (en) 1984-04-18
GB2085729A (en) 1982-05-06
JPS5770814A (en) 1982-05-01
DE3141223A1 (de) 1982-06-24
FR2492260B1 (enrdf_load_stackoverflow) 1984-07-27
FR2492260A1 (fr) 1982-04-23

Similar Documents

Publication Publication Date Title
ES506320A0 (es) Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.
ES504291A0 (es) Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
ES491970A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles, sustituidos en posicion 5 o 6 con un anillo de piridazinona
ES507595A0 (es) Un procedimiento para la produccion de un plasmido recombi- nante.
ES518875A0 (es) Procedimiento para la produccion de n-aril-sulfonil-n'-pirimidil-ureas.
ES521894A0 (es) Un procedimiento para la preparacion de nuevos cromenos y cromanos.
ES528628A0 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES487852A0 (es) Un procedimiento para la preparacion de interferon tipo ii.
IT8021112A0 (it) Procedimento ed apparecchiatura per comporre la carcassa di un pneumatico.
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
ES524271A0 (es) Un procedimiento para la preparacion de nuevos derivados de daunorrubicina y doxorrubicina.
ES507507A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES545574A0 (es) Un procedimiento para la preparacion bihidropiridanonas triciclicas.
ES535120A0 (es) Un procedimiento para la produccion de peptidos.
ES512914A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
ES506316A0 (es) Un procedimiento para la preparacion de nuevos peptidos con actividad analgesica
NL192063B (nl) Drukschakelaar.
ES540748A0 (es) Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.
ES498128A0 (es) Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos.
ES512079A0 (es) "un procedimiento para la preparacion de nuevos acilderivados de cefalosporina".
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES498945A0 (es) Un procedimiento para la preparacion de benzamidas.
ES503485A0 (es) Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980203